Biden administration awards $231M to increase US production of at-home, OTC COVID-19 test
Dive Brief: The U.S. Department of Defense, in coordination with HHS, awarded $231.8 million to Australia's Ellume to expand U.S. production of a rapid at-home test for COVID-19. The contract, awarded Monday, includes the purchase of 8.5 million antigen tests for nationwide distribution as part of President Joe Biden's pandemic response effort. Ellume's product, the first over-the-counter self-test for COVID-19 to receive FDA emergency use authorization, was developed with a $30 million contract from the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) initiative. Div...